Home › Trials › Lung

Lung cancer (small cell)

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Who can joinAdults

Age18+ years

Kind of studyPhase 2: does it work?

What it testsA medicine

The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.

Where to go

2 hospitals in India taking patients for this trial.

Caritas Hospital and Institute of Health SciencesKottayam, KeralaDirections ↗

Rajiv Gandhi Cancer Institute And Research CentreNew Delhi, National Capital Territory of DelhiDirections ↗

Registry summary (technical)

This study is being done to learn more about a new medicine called PF-08634404. The study team wants to understand how well PF-08634404 works when given alone or with chemotherapy . Chemotherapy is a type of cancer treatment that uses medicines to destroy cancer cells or stop them from growing. The study is for adults with Transformed Small Cell Lung Cancer (T-SCLC ). T SCLC is a rare lung cancer that happens when one type of lung cancer changes into a more aggressive type after treatment stops working. To join the study, participants must meet the following conditions: * Are aged 18 years o…

Sponsor: Pfizer
NCT07476287 on ClinicalTrials.gov
Last updated on the registry 9 Oct 2026 · read by us 20 Oct 2026

Lung cancer (small cell)

Where to go

Need help reaching the trial team? Write to us.